Northwest Biotherapeutics Inc (NWBO)
0.477
+0.02
(+3.67%)
USD |
OTCM |
Apr 25, 16:00
Northwest Biotherapeutics Profit Margin (Quarterly): -4.25K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.25K% |
| September 30, 2023 | -4.58K% |
| June 30, 2023 | -7.19K% |
| March 31, 2023 | -1.21K% |
| December 31, 2022 | -4.74K% |
| September 30, 2022 | -15.95K% |
| June 30, 2022 | -6.22K% |
| March 31, 2022 | -3.53K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -1.73K% |
| December 31, 2020 | -55.73K% |
| September 30, 2020 | -89.86K% |
| June 30, 2020 | -2.90M% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -1.07K% |
| June 30, 2019 | 37.69% |
| March 31, 2019 | -6.18K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -7.62K% |
| March 31, 2018 | -16.32K% |
| December 31, 2017 | -84.37K% |
| Date | Value |
|---|---|
| September 30, 2017 | -15.72K% |
| June 30, 2017 | -11.65K% |
| March 31, 2017 | -18.56K% |
| December 31, 2016 | -43.25K% |
| September 30, 2016 | -18.38K% |
| June 30, 2016 | -9.03K% |
| March 31, 2016 | -2.59K% |
| December 31, 2015 | -2.79K% |
| September 30, 2015 | |
| June 30, 2015 | -17.10K% |
| March 31, 2015 | -23.93K% |
| December 31, 2014 | -4.90K% |
| September 30, 2014 | -3.62K% |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -5.73K% |
| June 30, 2013 | -4.26K% |
| March 31, 2013 | -10.51K% |
| December 31, 2012 | -9.48K% |
| September 30, 2012 | -13.75K% |
| June 30, 2012 | -3.08K% |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.90M%
Minimum
Jun 2020
37.69%
Maximum
Jun 2019
-221.3K%
Average
-4.66K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -205.9% |
| Operating Margin (Quarterly) | -3.40K% |
| Return on Net Operating Assets | -265.3% |